FOXP3 and cervical cancer: Another approach was pursued by Someya et al. Based on CD8, FoxP3, HLA-1, PD-L1, and XRCC4 expression, they classified a set of 100 cervical cancers treated with CRT in “inflamed”, “excluded” and “cold” tumors.